These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial. Tulloch HE, Pipe AL, Els C, Clyde MJ, Reid RD. BMC Med; 2016 Jun 07; 14():80. PubMed ID: 27233840 [Abstract] [Full Text] [Related]
43. Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled. Wu L, Sun S, He Y, Zeng J. Int J Environ Res Public Health; 2015 Aug 25; 12(9):10235-53. PubMed ID: 26308034 [Abstract] [Full Text] [Related]
46. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R. Health Technol Assess; 2006 Mar 25; 10(9):1-132. iii-iv. PubMed ID: 16545208 [Abstract] [Full Text] [Related]
48. Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study. West R, Zhou X. Thorax; 2007 Nov 25; 62(11):998-1002. PubMed ID: 17573444 [Abstract] [Full Text] [Related]
51. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial. Li J, Hajek P, Pesola F, Wu Q, Phillips-Waller A, Przulj D, Myers Smith K, Bisal N, Sasieni P, Dawkins L, Ross L, Goniewicz ML, McRobbie H, Parrott S. Addiction; 2020 Mar 25; 115(3):507-517. PubMed ID: 31597207 [Abstract] [Full Text] [Related]
52. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence. Ekpu VU, Brown AK. Tob Use Insights; 2015 Mar 25; 8():1-35. PubMed ID: 26242225 [Abstract] [Full Text] [Related]
53. Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation. Lam TH, Abdullah AS, Chan SS, Hedley AJ, Hong Kong Council on Smoking and Health Smoking Cessation Health Centre (SCHC) Steering Group. Psychopharmacology (Berl); 2005 Feb 25; 177(4):400-8. PubMed ID: 15289997 [Abstract] [Full Text] [Related]
57. Reduction versus abrupt cessation in smokers who want to quit. Lindson N, Aveyard P, Hughes JR. Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008033. PubMed ID: 20238361 [Abstract] [Full Text] [Related]
59. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Ferguson SG, Gitchell JG, Shiffman S, Sembower MA. Clin Ther; 2009 Sep 17; 31(9):1957-65. PubMed ID: 19843485 [Abstract] [Full Text] [Related]
60. Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts. Levy DE, Thorndike AN, Biener L, Rigotti NA. Tob Control; 2007 Dec 17; 16(6):384-9. PubMed ID: 18048614 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]